Drug intelligence / Profile preview

cimetidine + tiotropium

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Inhalation
01

Overview

Cimetidine + tiotropium is a combination of two pharmaceutical agents with distinct mechanisms of action and clinical indications. Cimetidine is a small molecule histamine H2 receptor antagonist that competitively inhibits histamine binding at the H2 receptor in gastric parietal cells, leading to reduced gastric acid secretion. It is primarily used for the management of gastroesophageal reflux disease (GERD), peptic ulcer disease, and related conditions[8]. Tiotropium is a long-acting antimuscarinic bronchodilator (anticholinergic) that acts as an antagonist at muscarinic acetylcholine receptors M1 to M5 in airway smooth muscle—most notably inhibiting the M3 receptor—to induce bronchodilation. Tiotropium is indicated for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and asthma[2][6]. There are no fixed-dose combination products containing both drugs; however, they may be co-administered in certain clinical scenarios. No clinically significant pharmacokinetic interaction has been observed between these agents[4][5].

Brand names
Good Sense Heartburn Relief
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM3 (M3)CHRM5 (M5)CHRM2 (M2)CHRM4 (M4)HRH2 (Histamine H2 Receptor)

Beyond the preview

Go deeper on cimetidine + tiotropium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cimetidine + tiotropium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call